3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Neoplasms
1
Melanoma
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Drug-Related Side Effects and Adverse Reactions
1
Colorectal Adenocarcinoma
1
Carcinoma, Hepatocellular
1
Adenomatous Polyposis Coli
1
Interventions
Cisplatin
44
Paclitaxel
21
Radiotherapy
20
Brachytherapy
19
Carboplatin
18
Bevacizumab
7
Drug Therapy
6
camrelizumab
5
toripalimab
4
nimotuzumab
4
Radiation
4
Neoadjuvant Therapy
4
Gemcitabine
4
tislelizumab
3
sintilimab
3
pembrolizumab
3
apatinib
3
Vaccines
3
TP protocol
3
Surgical Procedures, Operative
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
nedaplatin
2
fludarabine
2
endostar protein
2
anlotinib
2
Topotecan
2
Surveys and Questionnaires
2
Sentinel Lymph Node Biopsy
2
Radiotherapy, Intensity-Modulated
2
Mindfulness
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Uterine Cervical Neoplasms
×
Pharmaceutical Preparations
×
Clear all
NCT02036164
2017-04-06
ACT-LACC
Navamindradhiraj University
Phase 3
Unknown
500 enrolled